Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.
about
Selected Aspects in the Pathogenesis of Autoimmune DiseasesVitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathyTherapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.Pathogenesis of dermatomyositis: role of cytokines and interferon.The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathiesTh1 response and systemic treg deficiency in inclusion body myositis.Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damageThe tumor necrosis factor superfamily of cytokines in the inflammatory myopathies: potential targets for therapy.Statistical insights into major human muscular diseases.Recent advances in the immunogenetics of idiopathic inflammatory myopathy.Biologic predictors of clinical improvement in rituximab-treated refractory myositisMyositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.A phase 1b clinical trial evaluating sifalimumab, an anti-IFN-α monoclonal antibody, shows target neutralisation of a type I IFN signature in blood of dermatomyositis and polymyositis patientsPathogenesis, classification and treatment of inflammatory myopathies.Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.Current pharmacological treatment of idiopathic inflammatory myopathies.The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review.Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study.Causes and consequences of endoplasmic reticulum stress in rheumatic disease.Novel approaches in the treatment of myositis and myopathies.Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study.Effect of butylphthalide intervention on experimental autoimmune myositis in guinea pigs.T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients
P2860
Q26795580-881417AC-1F23-4860-9F87-3EAB8A3DDE6FQ26849424-F347221E-44D9-4766-AD1C-9EEE18F8E43CQ33892454-D24F9B72-6876-4F6D-AD7A-904110760045Q34626955-141A53CD-1DDE-4CE4-871B-F789E921F922Q35035562-028F4ADC-92A2-4921-B93C-05D943402FCBQ35110718-368E11FA-6895-4119-87D8-A58EEC0F9CC2Q35125063-07A0E615-2DC1-453D-8EA7-4183B632373DQ35450066-3CF9C029-B7EA-4AF1-B871-ED332BFF7308Q35555230-22B4E5E1-631E-4E0A-8B1B-AE9BF9A54133Q35557800-A5C92768-60E3-4145-AEC4-12DE8A20AAB8Q35779841-F52E2147-F053-4F36-9C5E-1B156B8FD4E7Q37368405-1EF04C90-6907-4A28-9C65-F8C1180F9DD4Q37465544-227D6A05-99F8-4CBE-A952-BAF7AF5638AEQ37862083-BD9FAC90-A996-4B6F-AB75-86FF41A3DE02Q38255986-11812403-9057-4874-A2B6-8A5D148EB991Q38680762-A153F2EE-5D73-47ED-BFFA-ED55B29366F7Q38700961-5669E017-CDE2-48CF-832D-9D319E40A96FQ38813077-AE9A8EEC-A763-4D7A-BAB5-DE5B4A64A1E0Q39025066-DC1F32AD-6B49-4C26-B5C7-6BC2184E62C6Q41977818-1BD75121-78DF-40E4-9881-2315EC0B20D4Q47238762-F4796BF3-1625-4BFF-BF98-44C309C76672Q49221760-642ADCC3-98D4-475E-8E60-4E88E4B75E2DQ58695117-ECEF17F1-2296-43CC-A0D9-E55C205244EB
P2860
Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@ast
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@en
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@nl
type
label
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@ast
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@en
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@nl
prefLabel
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@ast
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@en
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@nl
P2093
P2860
P356
P1433
P1476
Idiopathic inflammatory myopat ...... proliferation inducing ligand.
@en
P2093
Andrea Ponyi
Annamaria T Nagy
Britt Nakken
Igor Dozmorov
Istvan Csipo
Katalin Danko
Michael Centola
Nicholas Knowlton
Philip Alex
Tamas Constantin
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ151
P577
2010-06-29T00:00:00Z